Neoadjuvant Now: What’s Next in Pre-Surgical Breast Cancer Treatment

by Biotech Newsroom


More breast cancer patients are now receiving treatment before surgery, also known as neoadjuvant therapy. But what’s next for this approach?

In this episode, our guest Dr Javier Cortes, Head of the International Breast Cancer Centre (IBCC) in Barcelona, shares insights into the latest neoadjuvant treatments being tested and how they could shape the future of breast cancer care.

Can you explain what neoadjuvant therapy is and why it’s used…



Source link

You may also like

Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Free Magazines

Recent Articles

BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC